Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy

J Vasc Interv Radiol. 2016 Mar;27(3):444-6. doi: 10.1016/j.jvir.2015.11.060.

Authors

Luca G Campana¹, Sara Valpione², Annalisa Tosi³, Marco Rastrelli¹, Carlo R Rossi¹, Camillo Aliberti⁴

Affiliations

¹ Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.
² Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.
³ Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.
⁴ Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.

PMID: 26916941
DOI: 10.1016/j.jvir.2015.11.060

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / administration & dosage
Bleomycin / administration & dosage
Electrochemotherapy*
Female
Hemangiosarcoma / diagnosis
Hemangiosarcoma / pathology
Hemangiosarcoma / therapy*
Humans
Lymphangiosarcoma / diagnosis
Lymphangiosarcoma / pathology
Lymphangiosarcoma / therapy*
Melphalan / administration & dosage
Middle Aged
Neoplasm Recurrence, Local
Perfusion / methods*
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha / administration & dosage

Substances

Antineoplastic Agents
Tumor Necrosis Factor-alpha
Bleomycin
Melphalan

Supplementary concepts

Stewart Treves syndrome